UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| | | |
| Date of Report (Date of Earliest Event Reported): | | November 12, 2004 |
Bell Microproducts Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| | | |
| California | 0-21528 | 94-3057566 |
_____________________
(State or other jurisdiction | _____________
(Commission | ______________
(I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| | | |
| 1941 Ringwood Avenue, San Jose, California | | 95131-1721 |
_________________________________
(Address of principal executive offices) | | ___________
(Zip Code) |
| | | |
| Registrant’s telephone number, including area code: | | 408-451-9400 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On November 12, 2004, Bell Microproducts Inc. (the "Company") and Congress Financial Corporation entered into the Fourth Amendment to Loan and Security Agreement, amending the terms of the Loan and Security Agreement to permit the Company to issue 3 3/4% Convertible Subordinated Notes, Series B due 2024 in the aggregate principal amount of up to $110,000,000 in exchange for outstanding 3 3/4% Convertible Subordinated Notes due 2024 in the aggregate principal amount of up to $110,000,000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | Bell Microproducts Inc. |
| | | | | |
| November 17, 2004 | | By: | | James E. Illson
|
| | | | |
|
| | | | | Name: James E. Illson |
| | | | | Title: Executive Vice President, Finance and Operations and Chief Financial Officer |
